Dr. Dan Ilkovitch, MD, PhD

Dr. Ilkovitch practices at Schweiger Dermatology Group in Lady Lake, Florida.

Dr. Ilkovitch's NPI, 1447512827, was assigned on June 12, 2012. Dr. Ilkovitch graduated from University of Miami, Miller School of Medicine in 2011. Dr. Ilkovitch holds Florida license ME121597.

Dr. Ilkovitch's primary practice is Schweiger Dermatology Group, at 1503 Buenos Aires Blvd, Lady Lake, FL 32159 in Lake County. The practice phone is (352) 365-6650.

Dr. Ilkovitch's primary practice is Schweiger Dermatology Group in Lady Lake, Florida. The medical group on file is Schweiger Dermatology Group. Dmand AI also links Dr. Ilkovitch to 2 more group practices and clinics, 1 physician office and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ilkovitch practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Ilkovitch's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Ilkovitch is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Ilkovitch's licenses on file in 2 states: Florida and Pennsylvania.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, corns and calluses and facial skin infection among the conditions Dr. Ilkovitch treats.

CMS data shows 1,683 Medicare services from Dr. Ilkovitch across 12 procedure codes in 2024, for 377 Medicare patients. Medicare paid $85,251 for them. Every service was in an office.

CMS counts 377 Medicare patients who saw Dr. Ilkovitch in 2024. The largest group is 65 to 74, with 211 patients. 75% of them have high cholesterol, and 68% have high blood pressure. Their average risk score is 0.98, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ilkovitch's median patient age at 68, with 45% women.

In 2024, Dr. Ilkovitch wrote 1,237 Medicare Part D claims for 451 patients. 99% of them were for generic drugs. CMS names the drug for 1,167 of them, across 22 drugs with 11 or more claims each, at $21,178 in total drug cost. In 2023, CMS named 1,209 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Ilkovitch for performance year 2024, reported individually. Dr. Ilkovitch accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ilkovitch as offering telehealth. CMS counts 475 procedures of removal of skin lesions by Dr. Ilkovitch, more than 86% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 19 papers to Dr. Ilkovitch, published from 2004 to 2021. 2009 was the busiest year, with 4. The most frequent topics are Mice, Inbred BALB C, Urokinase-Type Plasminogen Activator and Myeloid Cells. Dr. Ilkovitch has published most often in Cancer Res. Dr. Ilkovitch's most frequent co-authors are Trevor Jack Batty, DO, Raul Caso, MD and Kiran Motaparthi, MD.

CMS Open Payments shows 492 general payments to Dr. Ilkovitch from 33 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. Abbvie Inc. paid the most, $1,942.

Dr. Ilkovitch graduated from University of Miami, Miller School of Medicine in 2011.

Dr. Ilkovitch is in network with 18 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 12. Check the plan with the practice before a visit.